Due to unforeseen circumstances, The Anatomy of the Smile Webinar sponsored by pharmaceutical company Galderma has been postponed until March 11.
Pharmaceutical company Galderma has launched a new dermal filler winter marketing campaign to support its customers in promoting their business in the run-up to the festive period.
Aesthetics reports on the highlights from the British Association of Cosmetic Nurses Autumn Conference
Aesthetic practitioner and medical director of the Laser and Light Cosmetic Medical Skin Clinic, Dr Tahera Bhojani-Lynch has won the award for best European paper award in Plastic and Reconstructive Surgery – Global Open for 2017.
International pharmaceutical company Galderma has launched its new ‘Summer You – What’s Your Secret?’ dermal filler social media campaign today.
Two of the industry’s leading companies could become one if a multi-million dollar bid by Galderma to acquire Q-Med goes ahead. In a joint venture between L’Oreal and Nestle. Galderma, the makers of Azzalure®, launched a reported $970 million bid for the Swedish manufacturer of Restylane® at the end of 2010.
Pharmaceutical company Galderma has launched a global consumer campaign that aims to build trust in aesthetic treatments.
International pharmaceutical company Galderma has expanded the Galderma Aesthetics Academy Faculty with more key opinion leaders joining the team. The Faculty will also be refining a series of masterclasses with a focus on treatment selection for both the full face and individual features, like the lips.
The Food and Drug Administration (FDA) has approved Restylane Refyne and Restylane Defyne dermal fillers from Galderma for the treatment of nasolabial folds.
International pharmaceutical company Galderma has launched a new hologram on all packaging across the entire Restylane portfolio of Non-Animal Stabilised HA (NASHA) and Optimal Balance Technology (OBT) products, as well as the Skinboosters range to provide practitioners with further assurance that the products are original.